ECMO Treatment of Children in China in the Past 10 Years

Child, Only Clinical Trial

Official title:

Extracorporeal Membrane Oxygenation (ECMO) Treatment of Children in Mainland China in the Past 10 Years

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04709432
• Other study ID #: fdpicu-06
• Status: Recruiting
• Start date: January 11, 2021
• Est. completion date: December 31, 2024

Study information

• Verified date: February 2024
• Source: Children's Hospital of Fudan University
• Contact: YING JIAYUN
• Phone: 18817583962
• Email: jiayundoctor[@]163.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

It is a cross-sectional study to summarize the extracorporeal membrane oxygenation （ECMO）treatment in children in China.

Description:

ECMO treatment in children is still in its infancy in China, and it has made considerable progress in recent years. In order to further understand the development of ECMO treatment in critically ill children, the investigator conduct this cross-sectional research through questionnaires. The investigator collect general information of the hospital and ECMO equipment, etiology, compilation, and mode of ECMO.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 500
• Est. completion date: December 31, 2024
• Est. primary completion date: December 31, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 1 Day to 18 Years

Eligibility

Inclusion Criteria:

• age of 1d to 18 years old;

• children supported by ECMO in mainland China in the past 10 years

Exclusion Criteria:

• none

Related Conditions & MeSH terms

• Child, Only
• Extracorporeal Membrane Oxygenation

Intervention

Procedure:
• ECMO
ECMO is a form of Extracorporeal Life Support (ECLS) to support either the pulmonary, or both the pulmonary and cardiac systems.

Locations

Country	Name	City	State
China	Children's Hospital of Fudan University	Shanghai	Shanghai

Sponsors (1)

Lead Sponsor	Collaborator
Children's Hospital of Fudan University

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	survival rate	survival rate after discharge	from admission to discharge (about 10days)
Secondary	time of running ECMO	the total time of running ECMO	from admission to discharge(about 10days)
Secondary	cost of ECMO treatment	the total cost of ECMO treatment	from admission to discharge (about 10days)